Search

everythinglearnresearchcommunity

for

Search:↓

A rare skin condition affected only the facial hair of a 46-year-old man.

Microinfusion using tattoo devices effectively treats hair loss and skin conditions with minimal side effects.

Low-dose oral minoxidil is increasingly used by dermatologists in the UK and Ireland to treat various hair loss conditions.

Lichen planopilaris may have a genetic link.

Mitochondrial dysfunction and oxidative stress may play a role in Lichen Planopilaris.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

Various substances, including cosmetic sponges, vein glue, chai tea, skincare products, and medicaments, can cause allergic contact dermatitis, and healthcare workers often react to N95 masks.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

New hair treatment methods are evolving, with microneedling as a promising technique for hair growth.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

Retinoids can both cause and treat different hair disorders.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

The document discusses hair and nail conditions, updates on treatments for alopecia, and controversies around finasteride use.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

The document concludes that there have been significant advances in the treatment and diagnosis of various skin conditions.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

HIF-1A may aid hair growth, Backhousia citriodora improves skin, autologous cells stabilize hair loss, infrared thermography assesses alopecia, and a new treatment preserves hair.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

The document discusses various nail and hair disorders and their treatments.

Lichen planopilaris is more common in older women and may be linked to hormone therapy and autoimmune diseases.

Oral Minoxidil effectively treats hair loss with increased hair growth as a side effect, and low doses are generally safe.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

A cat developed a skin lesion from a topical solution, which healed with minoxidil treatment.